OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2012
(2)
2018
(1)
2016
(1)
2013
(1)
2011
(1)
2010
(1)
2009
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.
Not available
S-EPMC3772723
|
biostudies-literature
Cite
Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.
Not available
S-EPMC2938473
|
biostudies-literature
Cite
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Not available
S-EPMC6227755
|
biostudies-literature
Cite
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.
Not available
S-EPMC2737177
|
biostudies-literature
Cite
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
Not available
S-EPMC3209823
|
biostudies-literature
Cite
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
Not available
S-EPMC3413660
|
biostudies-literature
Cite
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Not available
S-EPMC4630206
|
biostudies-literature
Cite
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Not available
S-EPMC3670748
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets